RHPI:COMMERCIAL-STRATEGY

Pfizer slashes earnings forecast on decrease COVID gross sales, will lower prices

A corporate brand is noticed at a Pfizer administrative center in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/Record Photograph Achieve Licensing RightsOct 13 (Reuters) – Pfizer (PFE.N) on Friday slashed its full-year

October 14, 2023

OpenAI

Nestle replaces CEO Schneider with corporate veteran Freixe

Merchandise 1 of two Laurent Freixe of Nestle, smiles throughout an interview in Mexico Town, Mexico, March 3, 2020. Image taken, March 3, 2020. REUTERS/Edgard Garrido CEO/Report Picture[1/2]Laurent Freixe of Nestle, smiles

August 23, 2024

Business

Wall Boulevard indexes rally on bets of height US rates of interest, robust profits

Qualcomm positive factors as Q1 forecast tops estimatesStarbucks rises on upbeat quarterly resultsPayPal up on benefit forecast raiseWeekly jobless claims more potent than expectedIndexes up: Dow 1.7%, S&P 1.89%, Nasdaq 1.78percentNov 2

November 3, 2023

Business

Not like Pfizer, Moderna can meet 2023 COVID forecast, analysts say

Syringes with needles are noticed in entrance of a displayed Moderna emblem on this representation taken, November 27, 2021. REUTERS/Dado Ruvic/Representation/Record Photograph Gain Licensing RightsNov 1(Reuters) – Moderna (MRNA.O) must hit the

November 1, 2023

Health

Pfizer appears to be like past COVID as Paxlovid price sparks swing to quarterly loss

Paxlovid, Pfizer’s anti-viral drugs to regard the coronavirus illness (COVID-19), is displayed on this image representation taken October 7, 2022. REUTERS/Wolfgang Rattay/Representation/Record Photograph Achieve Licensing RightsOct 31 (Reuters) – Pfizer (PFE.N) on

October 31, 2023

Business

Wall Boulevard ends blended as Treasury yields ease, focal point turns to profits

Chevron slips after $53 bln deal for HessWalgreens up following JPM upgradeFMC slides after reducing Q3 outlookIndexes: Dow down 0.58%, S&P off 0.17%, Nasdaq up 0.27percentNEW YORK, Oct 23 (Reuters) – U.S.

October 24, 2023

Business

RHPI:COMMERCIAL-STRATEGY

Pfizer slashes earnings forecast on decrease COVID gross sales, will lower prices

Nestle replaces CEO Schneider with corporate veteran Freixe

Wall Boulevard indexes rally on bets of height US rates of interest, robust profits

Not like Pfizer, Moderna can meet 2023 COVID forecast, analysts say

Pfizer appears to be like past COVID as Paxlovid price sparks swing to quarterly loss

Wall Boulevard ends blended as Treasury yields ease, focal point turns to profits

Recent Posts

Categories

Suggestions

RHPI:COMMERCIAL-STRATEGY

Pfizer slashes earnings forecast on decrease COVID gross sales, will lower prices

Nestle replaces CEO Schneider with corporate veteran Freixe

Wall Boulevard indexes rally on bets of height US rates of interest, robust profits

Not like Pfizer, Moderna can meet 2023 COVID forecast, analysts say

Pfizer appears to be like past COVID as Paxlovid price sparks swing to quarterly loss

Wall Boulevard ends blended as Treasury yields ease, focal point turns to profits

Recent Posts

Categories